Lactate clamp: a method to measure lactate utilization in vivo

被引:6
作者
Gao, JP [1 ]
Islam, MA [1 ]
Brennan, CM [1 ]
Dunning, BE [1 ]
Foley, JE [1 ]
机构
[1] Novartis Pharmaceut Corp, Diabet Pharmacol Unit, Summit, NJ 07901 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1998年 / 275卷 / 04期
关键词
lactate infusion; lactate production; dichloroacetate;
D O I
10.1152/ajpendo.1998.275.4.E729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A lactate clamp method has been developed to quantify the whole body lactate utilization in conscious, unstressed rats. Dichloroacetate (DCA), a known lactate utilization enhancer, was used to validate the method. Fasting blood lactate concentrations before the clamps were identical for DCA-treated(1 mmol/kg) and control groups (1.65 +/- 0.37 vs. 1.65 +/- 0.19 mM). The animals received a primed continuous lactate infusion for 90 min at variable rates to clamp the blood lactate concentration at 2 mM. The steady-state (60-90 min) lactate infusion rate, which represents the whole body lactate utilization in DCA-treated animals, was 144% higher than that in the control animals (13.2 +/- 1.0 vs. 5.4 +/- 1.1 mg.kg(-1).min; P < 0.001). The markedly increased lactate infusion rate indicates an enhanced lactate flux by DCA. To determine whether the increased lactate infusion by DCA reflected reduced endogenous lactate production, lactate production was measured. The results indicate that endogenous lactate production was not affected by DCA. In conclusion, the lactate clamp provides a sensitive and reliable method to assess lactate utilization in vivo, a dynamic measurement that may not be clearly demonstrated by blood lactate concentrations per se.
引用
收藏
页码:E729 / E733
页数:5
相关论文
共 19 条
[1]   ROLE OF THE CIRCULATION IN MEASUREMENT OF LACTATE TURNOVER RATE [J].
BINDER, ND ;
DAY, D ;
BATTAGLIA, FC ;
MESCHIA, G ;
SPARKS, JW .
JOURNAL OF APPLIED PHYSIOLOGY, 1991, 70 (04) :1469-1476
[2]  
BROOKS GA, 1986, FASEB J, V45, P2924
[3]  
BROOKS GA, 1985, MED SCI SPORT EXER, V17, P22
[4]   PREDOMINANT ROLE OF GLUCONEOGENESIS IN INCREASED HEPATIC GLUCOSE-PRODUCTION IN NIDDM [J].
CONSOLI, A ;
NURJHAN, N ;
CAPANI, F ;
GERICH, J .
DIABETES, 1989, 38 (05) :550-557
[5]   Mammalian carbohydrate metabolism [J].
Cori, CF .
PHYSIOLOGICAL REVIEWS, 1931, 11 (02) :143-275
[6]   MECHANISM RESPONSIBLE FOR THE HYPOGLYCEMIC ACTIONS OF DICHLOROACETATE AND 2-CHLOROPROPIONATE [J].
CRABB, DW ;
HARRIS, RA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1979, 198 (01) :145-152
[7]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[8]   EFFECTS OF OBESITY AND MATURITY-ONSET DIABETES MELLITUS ON L(+) LACTIC ACID METABOLISM [J].
DOAR, JWH ;
CRAMP, DG .
CLINICAL SCIENCE, 1970, 39 (02) :271-&
[9]  
Gao J, 1998, FASEB J, V12, pA429
[10]   ON THE DETERMINATION OF TURNOVER INVIVO WITH TRACERS [J].
KATZ, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :E417-E424